publications-banner
Information about pipeline products
The content contained is subject to congress/journal copyright permissions. No further reproduction is permitted without permission of the copyright owner.
Information about pipeline compounds or investigational uses of compounds does not imply FDA approval for these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the pipeline compounds or investigational uses will receive FDA approval. Daiichi Sankyo does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling.
PublicationView
Edoxaban
Predictive factors and clinical events associated with edoxaban interruption and heparin bridging strategy: EMIT-AF/VTE
T-DXd
Trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small-cell lung cancer: Primary results from the randomized, phase II DESTINY-Lung02 trial
HER3-DXd
HERTHENA-Lung01, a phase II trial of patritumab deruxtecan (HER3-DXd) in epidermal growth factor receptor-mutated non-small-cell lung cancer after epidermal growth factor receptor tyrosine kinase inhibitor therapy and platinum-based chemotherapy
Edoxaban
Incidence and risk factors for venous thromboembolism in the Cancer-VTE registry pancreatic cancer subcohort
HER3-DXd
Treatment patterns and adverse event-related hospitalization among patients with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer after treatment with EGFR tyrosine kinase inhibitor and platinum-based chemotherapy regimens
Edoxaban
Prescription of DOACs in patients with atrial fibrillation at different stages of renal insufficiency
Edoxaban
Edoxaban use in the context of dental procedures: Analysis from the EMIT-AF/VTE database
Valemetostat
Safety, tolerability, and pharmacokinetics of valemetostat tablets and the effect of food on valemetostat pharmacokinetics in healthy subjects: Two phase 1 studies
Edoxaban
Comprehension of nonvalvular atrial fibrillation and anticoagulant adherence in elderly patients in a subcohort study of the All Nippon Atrial fibrillation in the Elderly registry
T-DXd
Transition of average drug-to-antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography-tandem mass spectrometry